M.D. Anderson Cancer Center: all 3,044 studies

Page 30 of 31. Open to participants first (578), then studies with results posted, then the rest; newest registration first within each.

• RAD001 Plus Docetaxel in Patients With Metastatic Breast CancerTerminatedNCT00253318Phase 1
• Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast CancerTerminatedNCT00227656Phase 2
• Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2ACompletedNCT00221039Phase 4
• Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's DiseaseWithdrawnNCT00129753Phase 2
• Erlotinib and Docetaxel With Concomitant Boost Radiation Therapy (XRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT00113347Phase 1
• Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for CancerCompletedNCT00112996Phase 3
• Continuous Infusion of Campath-1H Followed by Subcutaneous Injections in Previously Treated Patients With Chronic Lymphocytic LeukemiaCompletedNCT00102661Phase 2
• Lonafarnib and Temozolomide in Treating Patients with Glioblastoma Multiforme That is Recurrent or Did Not Respond to Previous Treatment with TemozolomideActive, not recruitingNCT00102648Phase 1
• 4-HPR and FTI in Head and Neck Squamous Cell Carcinoma (HNSCC)TerminatedNCT00102635Phase 1
• Intraperitoneal tgDCC-E1 and Intravenous Paclitaxel in Women With Platinum-Resistant Ovarian CancerTerminatedNCT00102622Phase 1
• PTK 787 and Gleevec in Patients With AML, AMM, and CML-BPCompletedNCT00088231Phase 1/2
• Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid TumorsCompletedNCT00086762Not applicable
• PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube CancerTerminatedNCT00085384Phase 1/2
• Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap SmearsCompletedNCT00084903Not applicable
• Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008CompletedNCT00084825Phase 2
• Use of Nesiritide in the Management of Acute Diastolic Heart FailureTerminatedNCT00083772Phase 4
• Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate CancerCompletedNCT00082732Phase 1
• Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the UrotheliumCompletedNCT00082719Phase 1
• Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal RemnantActive, not recruitingNCT00082706Phase 2
• Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic LeukemiaTerminatedNCT00081887Phase 1
• RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell LymphomaCompletedNCT00081874Phase 1/2
• Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate CancerCompletedNCT00080808Phase 2
• Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the UrotheliumCompletedNCT00080795Phase 2
• Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone MetastasesTerminatedNCT00080782Phase 2
• Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone MetastasesCompletedNCT00080678Phase 2
• Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid TumorsCompletedNCT00078845Phase 2
• TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)CompletedNCT00077142Phase 1/2
• Natrecor in Pulmonary HypertensionTerminatedNCT00075179Phase 4
• Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic SyndromesCompletedNCT00075010Phase 1/2
• Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous PlateletsTerminatedNCT00074763Phase 3
• Study of DT388GMCSF Fusion Protein in Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML)TerminatedNCT00074750Phase 1
• Alopecia Areata RegistryActive, not recruitingNCT00069589
• Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00068432Phase 2
• Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple MyelomaCompletedNCT00067639Phase 2
• Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic SyndromeCompletedNCT00065143Phase 2
• Phase II Randomized Bilateral Comparison of Topical Targretin Gel 1% in Alopecia AreataCompletedNCT00063076Phase 2/3
• Hepatic Artery Infusion of CD34+ CellsWithdrawnNCT00062543Phase 1
• Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal CancerTerminatedNCT00062023Phase 2
• Phase I Study of Continuous Infusion Schedule of FMdC in Hematologic MalignanciesCompletedNCT00061620Phase 1
• Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus MitoxantroneCompletedNCT00059631Phase 1
• PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube CancerCompletedNCT00059618Phase 1
• Phase I Study of IV DOTAP: Cholesterol-Fus1 in Non-Small-Cell Lung CancerCompletedNCT00059605Phase 1
• Interaction Between Patient and Healthcare Provider: Response to Acupuncture in Knee OsteoarthritisCompletedNCT00059345Not applicable
• Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving ChemotherapyWithdrawnNCT00052221Not applicable
• High-Dose Gleevec Alone or in Combination With Peg-Intron and GM-CSF in Early Phase Chronic Myelogenous Leukemia (CML)CompletedNCT00050531Phase 3
• Therapy of Early Chronic Phase CML With GleevecCompletedNCT00048672Phase 2
• Anti-Leukemic Dendritic Cell Activated Donor LymphocytesTerminatedNCT00048100Phase 1
• Iressa/Docetaxel in Non-Small-Cell Lung CancerWithdrawnNCT00048087Phase 2
• Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic CancerCompletedNCT00047710Phase 1
• Study of Lonafarnib and Gleevec in Chronic Myelogenous LeukemiaCompletedNCT00047502Phase 1
• Study of ABT-751 in Patients With Refractory Hematologic MalignanciesCompletedNCT00047489Phase 1
• Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast CancerCompletedNCT00046865Phase 3
• Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung CancerCompletedNCT00043823Phase 1/2
• Study of Gelonin Purging of Autologous Stem Cells for TransplantationTerminatedNCT00043810Phase 1/2
• IUdR/BUdR Cell Cycle LabellingCompletedNCT00042250Not applicable
• Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer PatientsTerminatedNCT00041782Phase 2
• Zarnestra and Gleevec in Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT00040105Phase 1
• Campath-1H and Allogeneic Blood Stem Cell Transplantation for Lymphoid MalignanciesTerminatedNCT00038883Not applicable
• Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated LymphocytesWithdrawnNCT00038870Not applicable
• Safety and Efficacy of Campath in Nonmyeloablative TransplantationCompletedNCT00038844Not applicable
• Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDSCompletedNCT00038831Phase 1/2
• CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell TransplantationTerminatedNCT00038818Not applicable
• Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS)TerminatedNCT00038805Phase 2/3
• Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHDTerminatedNCT00038792Phase 1/2
• Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure StatesTerminatedNCT00038779Not applicable
• Study of Gemcitabine Chemoradiation and TNP-470 Patients Locally Advanced, Nonmetastatic Adenocarcinoma of PancreasTerminatedNCT00038701Phase 2
• Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell LymphomaCompletedNCT00038623Phase 2
• Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)CompletedNCT00038597Phase 2
• A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell CancerCompletedNCT00038584Phase 1
• Proteasome Inhibitor PS-341 Relapsed or Refractory B Cell Lymphomas Previously Treated With ChemotherapyCompletedNCT00038571Phase 2
• Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD ChemotherapyCompletedNCT00038558Phase 3
• A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's LymphomaCompletedNCT00038545Phase 2
• Temozolomide and SCH66336 for Recurrent Glioblastoma MultiformeCompletedNCT00038493Phase 2
• Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant GliomasCompletedNCT00038441Phase 1/2
• A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic ApproachTerminatedNCT00038415Phase 1/2
• Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast CancerCompletedNCT00038402Phase 3
• Study of Vioxx and Radiation Therapy for Brainstem GliomaTerminatedNCT00038389Phase 1
• Phase II Study Of Roferon and Accutane For Patients With T-Cell MalignanciesCompletedNCT00038376Phase 2
• Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate CarcinomaCompletedNCT00038246Phase 1/2
• Thalidomide for Multiple MyelomaCompletedNCT00038233Phase 3
• Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed MalignanciesCompletedNCT00038207Phase 2
• Phase I Trial of Fixed Dose STI571 (Imatinib Mesylate) With Escalating Doses of Docetaxel in Patients With Metastatic Androgen-Independent Prostate CancerCompletedNCT00038194Phase 1
• Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select Patients With Locally Advanced Prostate CancerCompletedNCT00038181Phase 2
• Intravenous Estramustine With Taxol in Hormone Refractory Prostate AdenocarcinomaCompletedNCT00038168Phase 1/2
• Thalidomide-Dexamethasone for Multiple MyelomaCompletedNCT00038090Phase 2/3
• Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid MalignanciesCompletedNCT00038051Phase 1
• Assessment of Head and Neck Tumor Hypoxia Using 18F-FluoromisonidazoleWithdrawnNCT00038038Not applicable
• A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid MalignanciesCompletedNCT00038025Phase 2
• rhTPO Mobilized Auto Cryo Platelets For GYN Patients Receiving CarboplatinCompletedNCT00038012Not applicable
• PEG-Intron For Chronic Myelogenous Leukemia Patients Unresponsive To Or Intolerant Of Roferon Or IntronTerminatedNCT00037882Phase 2
• High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine TumorsCompletedNCT00037869Phase 3
• Iodine I-131 Iodocholesterol, Its Use in Adrenal ScreeningCompletedNCT00037843Phase 3
• Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer PatientsCompletedNCT00037609Phase 1/2
• Clofarabine in Chronic Lymphocytic LeukemiaCompletedNCT00028418Phase 1
• Imatinib Mesylate in Treating Patients With Metastatic MelanomaCompletedNCT00027586Phase 2
• Bortezomib in Treating Patients With Chronic Myelogenous LeukemiaTerminatedNCT00023881Phase 2
• Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00016367Phase 2
• Docetaxel in Treating Patients With Metastatic Breast CancerCompletedNCT00008411Phase 3
• Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00006471Phase 2
• Arsenic Trioxide in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Has Not Responded to Previous TreatmentWithdrawnNCT00006091Phase 2

← M.D. Anderson Cancer Center overview and focus areas